Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data
- PMID: 31580171
- DOI: 10.1080/10428194.2019.1672057
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources